Europe - Frankfurt Stock Exchange - FRA:AAQ1 - DE000A3H2101 - Common Stock
The current stock price of AAQ1.DE is 1.52 EUR. In the past month the price increased by 13.43%. In the past year, price decreased by -1.94%.
ChartMill assigns a technical rating of 5 / 10 to AAQ1.DE. When comparing the yearly performance of all stocks, AAQ1.DE turns out to be only a medium performer in the overall market: it outperformed 44.28% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. The financial health of AAQ1.DE is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 63.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.96% | ||
| ROE | -38.7% | ||
| Debt/Equity | 0.03 |
For the next year, analysts expect an EPS growth of 65% and a revenue growth 15.38% for AAQ1.DE
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
AAP IMPLANTATE
Lorenzweg 5
Berlin BERLIN DE
Employees: 87
Phone: 4930750190
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
The current stock price of AAQ1.DE is 1.52 EUR.
AAQ1.DE does not pay a dividend.
AAQ1.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
AAP IMPLANTATE (AAQ1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The Revenue of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 15.38% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
You can find the ownership structure of AAP IMPLANTATE (AAQ1.DE) on the Ownership tab.